KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeMD (LFMD) EBIT Margin (2016 - 2025)

LifeMD's EBIT Margin history spans 14 years, with the latest figure at 87.9% for Q4 2025.

  • For Q4 2025, EBIT Margin rose 2089.0% year-over-year to 87.9%; the TTM value through Dec 2025 reached 3.57%, up 1105.0%, while the annual FY2025 figure was 3.95%, 923.0% up from the prior year.
  • EBIT Margin reached 87.9% in Q4 2025 per LFMD's latest filing, down from 3.27% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 3.28% in Q1 2025 to a low of 108.78% in Q4 2024.
  • Average EBIT Margin over 5 years is 32.77%, with a median of 18.24% recorded in 2022.
  • Peak YoY movement for EBIT Margin: skyrocketed 20089bps in 2021, then crashed -10394bps in 2024.
  • A 5-year view of EBIT Margin shows it stood at 49.84% in 2021, then grew by 26bps to 36.88% in 2022, then soared by 87bps to 4.84% in 2023, then plummeted by -2147bps to 108.78% in 2024, then grew by 19bps to 87.9% in 2025.
  • Per Business Quant, the three most recent readings for LFMD's EBIT Margin are 87.9% (Q4 2025), 3.27% (Q3 2025), and 0.92% (Q2 2025).